1 Market Overview

1.1 Product Overview and Scope of Oncolytic Virus Therapy

1.2 Classification of Oncolytic Virus Therapy by Type

1.2.1 Overview: Global Oncolytic Virus Therapy Revenue by Type: 2015 Versus 2019 Versus 2025

1.2.2 Global Oncolytic Virus Therapy Revenue Market Share by Type in 2019

1.2.3 HSV-based Oncolytic Viruses

1.2.4 Adenoviruses-based Oncolytic Viruses

1.2.5 Vaccinia Virus-based Oncolytic Viruses

1.2.6 Vesicular Stomatitis Virus-based Oncolytic Viruses

1.2.7 Newcastle Disease Virus-based Oncolytic Viruses

1.3 Global Oncolytic Virus Therapy Market by Application

1.3.1 Overview: Global Oncolytic Virus Therapy Revenue by Application: 2015 Versus 2019 Versus 2025

1.3.2 Melanoma

1.3.3 Prostate Cancer

1.3.4 Breast Cancer

1.3.5 Ovarian Cancer

1.3.6 Others

1.4 Global Oncolytic Virus Therapy Market Size and Forecast (2015-2025)

1.5 Global Oncolytic Virus Therapy Market Size by Regions: 2015 VS 2019 VS 2025

1.6 Global Oncolytic Virus Therapy Market Size by Regions (2015-2020)

1.7 Global Oncolytic Virus Therapy Market Size and Forecast by Regions (2020-2025)

1.7.1 North America Oncolytic Virus Therapy Status and Prospect (2015-2025)

1.7.2 Europe Oncolytic Virus Therapy Status and Prospect (2015-2025)

1.7.3 Asia Oncolytic Virus Therapy Status and Prospect (2015-2025)

1.7.4 South America Oncolytic Virus Therapy Status and Prospect (2015-2025)

1.7.5 Middle East & Africa Oncolytic Virus Therapy Status and Prospect (2015-2025)

2 Company Profiles

2.1 Amgen

2.1.1 Amgen Details

2.1.2 Amgen Major Business

2.1.3 Amgen SWOT Analysis

2.1.4 Amgen Product and Services

2.1.5 Amgen Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019)

2.2 SillaJen Biotherapeutics

2.2.1 SillaJen Biotherapeutics Details

2.2.2 SillaJen Biotherapeutics Major Business

2.2.3 SillaJen Biotherapeutics SWOT Analysis

2.2.4 SillaJen Biotherapeutics Product and Services

2.2.5 SillaJen Biotherapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019)

2.3 Transgene SA

2.3.1 Transgene SA Details

2.3.2 Transgene SA Major Business

2.3.3 Transgene SA SWOT Analysis

2.3.4 Transgene SA Product and Services

2.3.5 Transgene SA Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019)

2.4 Oncolytics Biotech

2.4.1 Oncolytics Biotech Details

2.4.2 Oncolytics Biotech Major Business

2.4.3 Oncolytics Biotech SWOT Analysis

2.4.4 Oncolytics Biotech Product and Services

2.4.5 Oncolytics Biotech Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019)

2.5 PsiOxus Therapeutics

2.5.1 PsiOxus Therapeutics Details

2.5.2 PsiOxus Therapeutics Major Business

2.5.3 PsiOxus Therapeutics SWOT Analysis

2.5.4 PsiOxus Therapeutics Product and Services

2.5.5 PsiOxus Therapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019)

2.6 Viralytics

2.6.1 Viralytics Details

2.6.2 Viralytics Major Business

2.6.3 Viralytics Product and Services

2.6.4 Viralytics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019)

2.7 Lokon Pharma

2.7.1 Lokon Pharma Details

2.7.2 Lokon Pharma Major Business

2.7.3 Lokon Pharma Product and Services

2.7.4 Lokon Pharma Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019)

2.8 Targovax

2.8.1 Targovax Details

2.8.2 Targovax Major Business

2.8.3 Targovax Product and Services

2.8.4 Targovax Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019)

2.9 Oncolys BioPharma

2.9.1 Oncolys BioPharma Details

2.9.2 Oncolys BioPharma Major Business

2.9.3 Oncolys BioPharma Product and Services

2.9.4 Oncolys BioPharma Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019)

2.10 Sorrento Therapeutics

2.10.1 Sorrento Therapeutics Details

2.10.2 Sorrento Therapeutics Major Business

2.10.3 Sorrento Therapeutics Product and Services

2.10.4 Sorrento Therapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019)

2.11 Genelux Corporation

2.11.1 Genelux Corporation Details

2.11.2 Genelux Corporation Major Business

2.11.3 Genelux Corporation Product and Services

2.11.4 Genelux Corporation Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019)

2.12 Cold Genesys

2.12.1 Cold Genesys Details

2.12.2 Cold Genesys Major Business

2.12.3 Cold Genesys Product and Services

2.12.4 Cold Genesys Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019)

2.13 Vyriad

2.13.1 Vyriad Details

2.13.2 Vyriad Major Business

2.13.3 Vyriad Product and Services

2.13.4 Vyriad Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019)

2.14 TILT Biotherapeutics

2.14.1 TILT Biotherapeutics Details

2.14.2 TILT Biotherapeutics Major Business

2.14.3 TILT Biotherapeutics Product and Services

2.14.4 TILT Biotherapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2018-2019)

3 Market Competition, by Players

3.1 Global Oncolytic Virus Therapy Market Size by Players (2015-2020)

3.2 Japan Oncolytic Virus Therapy Market Size by Players (2015-2020)

3.3 Market Concentration Rate

3.3.1 Top 5 Oncolytic Virus Therapy Players Market Share

3.3.2 Top 10 Oncolytic Virus Therapy Players Market Share

4 North America Market Size and Forecast by Countries

4.1 North America Oncolytic Virus Therapy Market Size by Countries (2015-2020)

4.2 North America Oncolytic Virus Therapy Market Size and Forecast by Countries (2015-2026)

4.3 United States Oncolytic Virus Therapy Market Size and Forecast (2015-2025)

4.4 Canada Oncolytic Virus Therapy Market Size and Forecast (2015-2025)

4.5 Mexico Oncolytic Virus Therapy Market Size and Forecast (2015-2025)

5 Europe Market Size and Forecast by Countries

5.1 Europe Oncolytic Virus Therapy Market Size by Countries (2015-2020)

5.2 Europe Oncolytic Virus Therapy Market Size and Forecast by Countries (2015-2026)

5.3 Germany Oncolytic Virus Therapy Market Size and Forecast (2015-2025)

5.4 France Oncolytic Virus Therapy Market Size and Forecast (2015-2025)

5.5 UK Oncolytic Virus Therapy Market Size and Forecast (2015-2025)

5.6 Russia Oncolytic Virus Therapy Market Size and Forecast (2015-2025)

5.7 Italy Oncolytic Virus Therapy Market Size and Forecast (2015-2025)

6 Asia-Pacific Market Size and Forecast by Countries

6.1 Asia-Pacific Oncolytic Virus Therapy Market Size by Regions (2015-2020)

6.2 Asia-Pacific Oncolytic Virus Therapy Market Size and Forecast by Regions (2015-2026)

6.3 China Oncolytic Virus Therapy Market Size and Forecast (2015-2025)

6.4 Japan Oncolytic Virus Therapy Market Size and Forecast (2015-2025)

6.5 Korea Oncolytic Virus Therapy Market Size and Forecast (2015-2025)

6.6 India Oncolytic Virus Therapy Market Size and Forecast (2015-2025)

6.7 Southeast Asia Oncolytic Virus Therapy Market Size and Forecast (2015-2025)

7 South America Market Size and Forecast by Countries

7.1 South America Oncolytic Virus Therapy Market Size by Countries (2015-2020)

7.2 South America Oncolytic Virus Therapy Market Size and Forecast by Countries (2015-2026)

7.3 Brazil Oncolytic Virus Therapy Market Size and Forecast (2015-2025)

7.4 Argentina Oncolytic Virus Therapy Market Size and Forecast (2015-2025)

8 Middle East & Africa Market Size and Forecast by Countries

8.1 Middle East & Africa Oncolytic Virus Therapy Revenue by Regions (2015-2020)

8.2 Middle East & Africa Oncolytic Virus Therapy Market Size and Forecast by Countries (2015-2026)

8.3 Saudi Arabia Oncolytic Virus Therapy Market Size and Forecast (2015-2025)

8.4 UAE Oncolytic Virus Therapy Market Size and Forecast (2015-2025)

8.5 Egypt Oncolytic Virus Therapy Market Size and Forecast (2015-2025)

8.6 South Africa Oncolytic Virus Therapy Market Size and Forecast (2015-2025)

9 Market Size Segment by Type

9.1 Global Oncolytic Virus Therapy Market Size and Forecast by Type (2015-2025)

9.1.1 Global Oncolytic Virus Therapy Market Size by Type (2015-2020)

9.1.2 Global Oncolytic Virus Therapy Market Size Forecast by Type (2020-2025)

9.2 Japan Oncolytic Virus Therapy Market Size and Forecast by Type (2015-2025)

9.2.1 Japan Oncolytic Virus Therapy Market Size by Type (2015-2020)

9.2.2 Japan Oncolytic Virus Therapy Market Size Forecast by Type (2020-2025)

10 Market Size Segment by Application

10.1 Global Oncolytic Virus Therapy Market Size and Forecast by Application (2015-2025)

10.1.1 Global Oncolytic Virus Therapy Market Size by Application (2015-2020)

10.1.2 Global Oncolytic Virus Therapy Market Size Forecast by Application (2020-2025)

10.2 Japan Oncolytic Virus Therapy Market Size and Forecast by Application (2015-2025)

10.2.1 Japan Oncolytic Virus Therapy Market Size by Application (2015-2020)

10.2.2 Japan Oncolytic Virus Therapy Market Size Forecast by Application (2020-2025)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Data Source

12.3 Disclaimer

12.4 About US

List of Tables

Table 1. Global Oncolytic Virus Therapy Revenue (USD Million) by Type: 2015 Versus 2019 Versus 2025

Table 2. Breakdown of Oncolytic Virus Therapy by Company Type (Tier 1, Tier 2 and Tier 3)

Table 3. Global Oncolytic Virus Therapy Revenue (USD Million) by Application: 2015 Versus 2019 Versus 2025

Table 4. Global Market Oncolytic Virus Therapy Market Size (USD Million) Comparison by Regions (2020-2025)

Table 5. Global Oncolytic Virus Therapy Revenue (USD Million) by Regions (2015-2020)

Table 6. Global Oncolytic Virus Therapy Revenue Share by Regions (2015-2020)

Table 7. Global Oncolytic Virus Therapy Revenue (USD Million) by Regions (2020-2025)

Table 8. Global Oncolytic Virus Therapy Revenue Market Share by Regions (2020-2025)

Table 9. Global Oncolytic Virus Therapy Market Size and Growth Estimation in Various Scenarios in 2020

Table 10. Amgen Corporate Information, Location and Competitors

Table 11. Amgen Major Business

Table 12. Amgen Oncolytic Virus Therapy Total Revenue (USD Million) (2017-2018)

Table 13. Amgen SWOT Analysis

Table 14. Amgen Oncolytic Virus Therapy Product and Solutions

Table 15. Amgen Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 16. SillaJen Biotherapeutics Corporate Information, Location and Competitors

Table 17. SillaJen Biotherapeutics Major Business

Table 18. SillaJen Biotherapeutics Oncolytic Virus Therapy Total Revenue (USD Million) (2018-2019)

Table 19. SillaJen Biotherapeutics SWOT Analysis

Table 20. SillaJen Biotherapeutics Oncolytic Virus Therapy Product and Solutions

Table 21. SillaJen Biotherapeutics Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 22. Transgene SA Corporate Information, Location and Competitors

Table 23. Transgene SA Major Business

Table 24. Transgene SA Oncolytic Virus Therapy Total Revenue (USD Million) (2017-2018)

Table 25. Transgene SA SWOT Analysis

Table 26. Transgene SA Oncolytic Virus Therapy Product and Solutions

Table 27. Transgene SA Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 28. Oncolytics Biotech Corporate Information, Location and Competitors

Table 29. Oncolytics Biotech Major Business

Table 30. Oncolytics Biotech Oncolytic Virus Therapy Total Revenue (USD Million) (2017-2018)

Table 31. Oncolytics Biotech SWOT Analysis

Table 32. Oncolytics Biotech Oncolytic Virus Therapy Product and Solutions

Table 33. Oncolytics Biotech Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 34. PsiOxus Therapeutics Corporate Information, Location and Competitors

Table 35. PsiOxus Therapeutics Major Business

Table 36. PsiOxus Therapeutics Oncolytic Virus Therapy Total Revenue (USD Million) (2017-2018)

Table 37. PsiOxus Therapeutics SWOT Analysis

Table 38. PsiOxus Therapeutics Oncolytic Virus Therapy Product and Solutions

Table 39. PsiOxus Therapeutics Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 40. Viralytics Corporate Information, Location and Competitors

Table 41. Viralytics Major Business

Table 42. Viralytics Oncolytic Virus Therapy Total Revenue (USD Million) (2017-2018)

Table 43. Viralytics SWOT Analysis

Table 44. Viralytics Oncolytic Virus Therapy Product and Solutions

Table 45. Viralytics Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 46. Lokon Pharma Corporate Information, Location and Competitors

Table 47. Lokon Pharma Major Business

Table 48. Lokon Pharma Oncolytic Virus Therapy Total Revenue (USD Million) (2017-2018)

Table 49. Lokon Pharma SWOT Analysis

Table 50. Lokon Pharma Oncolytic Virus Therapy Product and Solutions

Table 51. Lokon Pharma Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 52. Targovax Corporate Information, Location and Competitors

Table 53. Targovax Major Business

Table 54. Targovax Oncolytic Virus Therapy Total Revenue (USD Million) (2017-2018)

Table 55. Targovax SWOT Analysis

Table 56. Targovax Oncolytic Virus Therapy Product and Solutions

Table 57. Targovax Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 58. Oncolys BioPharma Corporate Information, Location and Competitors

Table 59. Oncolys BioPharma Major Business

Table 60. Oncolys BioPharma Oncolytic Virus Therapy Total Revenue (USD Million) (2017-2018)

Table 61. Oncolys BioPharma SWOT Analysis

Table 62. Oncolys BioPharma Oncolytic Virus Therapy Product and Solutions

Table 63. Oncolys BioPharma Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 64. Sorrento Therapeutics Corporate Information, Location and Competitors

Table 65. Sorrento Therapeutics Major Business

Table 66. Sorrento Therapeutics Oncolytic Virus Therapy Total Revenue (USD Million) (2017-2018)

Table 67. Sorrento Therapeutics SWOT Analysis

Table 68. Sorrento Therapeutics Oncolytic Virus Therapy Product and Solutions

Table 69. Sorrento Therapeutics Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 70. Genelux Corporation Corporate Information, Location and Competitors

Table 71. Genelux Corporation Major Business

Table 72. Genelux Corporation Oncolytic Virus Therapy Total Revenue (USD Million) (2017-2018)

Table 73. Genelux Corporation SWOT Analysis

Table 74. Genelux Corporation Oncolytic Virus Therapy Product and Solutions

Table 75. Genelux Corporation Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 76. Cold Genesys Corporate Information, Location and Competitors

Table 77. Cold Genesys Major Business

Table 78. Cold Genesys Oncolytic Virus Therapy Total Revenue (USD Million) (2017-2018)

Table 79. Cold Genesys SWOT Analysis

Table 80. Cold Genesys Oncolytic Virus Therapy Product and Solutions

Table 81. Cold Genesys Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 82. Vyriad Corporate Information, Location and Competitors

Table 83. Vyriad Major Business

Table 84. Vyriad Oncolytic Virus Therapy Total Revenue (USD Million) (2017-2018)

Table 85. Vyriad SWOT Analysis

Table 86. Vyriad Oncolytic Virus Therapy Product and Solutions

Table 87. Vyriad Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 88. TILT Biotherapeutics Corporate Information, Location and Competitors

Table 89. TILT Biotherapeutics Major Business

Table 90. TILT Biotherapeutics Oncolytic Virus Therapy Total Revenue (USD Million) (2017-2018)

Table 91. TILT Biotherapeutics SWOT Analysis

Table 92. TILT Biotherapeutics Oncolytic Virus Therapy Product and Solutions

Table 93. TILT Biotherapeutics Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 94. Global Oncolytic Virus Therapy Revenue (USD Million) by Players (2015-2020)

Table 95. Global Oncolytic Virus Therapy Revenue Share by Players (2015-2020)

Table 96. Key Players Oncolytic Virus Therapy Revenue (USD Million) in Japan (2015-2020)

Table 97. Key Players Oncolytic Virus Therapy Revenue Share in Japan (2015-2020)

Table 98. North America Oncolytic Virus Therapy Revenue (USD Million) by Countries (2015-2020)

Table 99. North America Oncolytic Virus Therapy Revenue Market Share by Countries (2015-2020)

Table 100. North America Oncolytic Virus Therapy Revenue (USD Million) by Countries (2020-2026)

Table 101. North America Oncolytic Virus Therapy Revenue Market Share by Countries (2020-2026)

Table 102. Europe Oncolytic Virus Therapy Revenue (USD Million) by Countries (2015-2020)

Table 103. Europe Oncolytic Virus Therapy Revenue Market Share by Countries (2015-2020)

Table 104. Europe Oncolytic Virus Therapy Revenue (USD Million) by Countries (2020-2026)

Table 105. Europe Oncolytic Virus Therapy Revenue Market Share by Countries (2020-2026)

Table 106. Asia-Pacific Oncolytic Virus Therapy Revenue (USD Million) by Countries (2015-2020)

Table 107. Asia-Pacific Oncolytic Virus Therapy Revenue Market Share by Countries (2015-2020)

Table 108. Asia-Pacific Oncolytic Virus Therapy Revenue (USD Million) by Countries (2020-2026)

Table 109. Asia-Pacific Oncolytic Virus Therapy Revenue Market Share by Countries (2020-2026)

Table 110. South America Oncolytic Virus Therapy Revenue (USD Million) by Countries (2015-2020)

Table 111. South America Oncolytic Virus Therapy Revenue Market Share by Countries (2015-2020)

Table 112. South America Oncolytic Virus Therapy Revenue (USD Million) by Countries (2020-2026)

Table 113. South America Oncolytic Virus Therapy Revenue Market Share by Countries (2020-2026)

Table 114. Middle East & Africa Oncolytic Virus Therapy Revenue (USD Million) by Countries (2015-2020)

Table 115. Middle East & Africa Oncolytic Virus Therapy Revenue Market Share by Countries (2015-2020)

Table 116. Middle East & Africa Oncolytic Virus Therapy Revenue (USD Million) by Countries (2020-2026)

Table 117. Middle East & Africa Oncolytic Virus Therapy Revenue Market Share by Countries (2020-2026)

Table 118. Global Oncolytic Virus Therapy Revenue (USD Million) by Type (2015-2020)

Table 119. Global Oncolytic Virus Therapy Revenue Share by Type (2015-2020)

Table 120. Global Oncolytic Virus Therapy Revenue Forecast by Type (2020-2025)

Table 121. Global Oncolytic Virus Therapy Market Share Forecast by Type (2020-2025)

Table 122. Japan Oncolytic Virus Therapy Revenue (USD Million) by Type (2015-2020)

Table 123. Japan Oncolytic Virus Therapy Revenue Share by Type (2015-2020)

Table 124. Japan Oncolytic Virus Therapy Revenue Forecast by Type (2020-2025)

Table 125. Japan Oncolytic Virus Therapy Market Share Forecast by Type (2020-2025)

Table 126. Global Oncolytic Virus Therapy Revenue (USD Million) by Application (2015-2020)

Table 127. Global Oncolytic Virus Therapy Revenue Share by Application (2015-2020)

Table 128. Global Oncolytic Virus Therapy Revenue Forecast by Application (2020-2025)

Table 129. Global Oncolytic Virus Therapy Market Share Forecast by Application (2020-2025)

Table 130. Japan Oncolytic Virus Therapy Revenue (USD Million) by Application (2015-2020)

Table 131. Japan Oncolytic Virus Therapy Revenue Share by Application (2015-2020)

Table 132. Japan Oncolytic Virus Therapy Revenue Forecast by Application (2020-2025)

Table 133. Japan Oncolytic Virus Therapy Market Share Forecast by Application (2020-2025)

Table 134.List of Figures

Table 135. Oncolytic Virus Therapy Picture

Table 136. Global Oncolytic Virus Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Table 137. Global Oncolytic Virus Therapy Revenue Market Share by Type in 2019

Table 138. HSV-based Oncolytic Viruses Picture

Table 139. Adenoviruses-based Oncolytic Viruses Picture

Table 140. Vaccinia Virus-based Oncolytic Viruses Picture

Table 141. Vesicular Stomatitis Virus-based Oncolytic Viruses Picture

Table 142. Newcastle Disease Virus-based Oncolytic Viruses Picture

Table 143. Oncolytic Virus Therapy Revenue Market Share by Application in 2019

Table 144. Melanoma Picture

Table 145. Prostate Cancer Picture

Table 146. Breast Cancer Picture

Table 147. Ovarian Cancer Picture

Table 148. Others Picture

Table 149. Global Oncolytic Virus Therapy Revenue and Growth Rate (2015-2025) (USD Million)

Table 150. Global Oncolytic Virus Therapy Market Size Share by Regions (2015-2025)

Table 151. Global Oncolytic Virus Therapy Market Size Share by Regions in 2019

Table 152. Global Oncolytic Virus Therapy Revenue Market Share by Regions (2020-2025)

Table 153. North America Oncolytic Virus Therapy Revenue (USD Million) and Growth Rate (2015-2025)

Table 154. Europe Oncolytic Virus Therapy Revenue (USD Million) and Growth Rate (2015-2025)

Table 155. Asia-Pacific Oncolytic Virus Therapy Revenue (USD Million) and Growth Rate (2015-2025)

Table 156. South America Oncolytic Virus Therapy Revenue (USD Million) and Growth Rate (2015-2025)

Table 157. Middle East & Africa Oncolytic Virus Therapy Revenue (USD Million) and Growth Rate (2015-2025)

Table 158. Global Oncolytic Virus Therapy Revenue Share by Players in 2019

Table 159. Global Top 5 Players Oncolytic Virus Therapy Revenue Market Share in 2019

Table 160. Top 10 Players Oncolytic Virus Therapy Revenue Market Share in Global Market in 2019

Table 161. Global Oncolytic Virus Therapy Market Size (USD Million) by Type (2015-2025)

Table 162. Global Oncolytic Virus Therapy Market Size Share by Application (2015-2025)

Table 163. North America Oncolytic Virus Therapy Market Size Share by Countries (2015-2025)

Table 164. North America Oncolytic Virus Therapy Market Size Share by Countries in 2019

Table 165. United States Oncolytic Virus Therapy Market Size (USD Million) and Forecast (2015-2025)

Table 166. Canada Oncolytic Virus Therapy Market Size (USD Million) and Forecast (2015-2025)

Table 167. Mexico Oncolytic Virus Therapy Market Size (USD Million) and Forecast (2015-2025)

Table 168. Europe Oncolytic Virus Therapy Market Size Share by Countries (2015-2025)

Table 169. Europe Oncolytic Virus Therapy Market Size Share by Countries in 2019

Table 170. Germany Oncolytic Virus Therapy Market Size (USD Million) and Forecast (2015-2025)

Table 171. France Oncolytic Virus Therapy Market Size (USD Million) and Forecast (2015-2025)

Table 172. Russia Oncolytic Virus Therapy Market Size (USD Million) and Forecast (2015-2025)

Table 173. Italy Oncolytic Virus Therapy Market Size (USD Million) and Forecast (2015-2025)

Table 174. Spain Oncolytic Virus Therapy Market Size (USD Million) and Forecast (2015-2025)

Table 175. UK Oncolytic Virus Therapy Market Size (USD Million) and Forecast (2015-2025)

Table 176. Asia Oncolytic Virus Therapy Market Size Share by Countries (2015-2025)

Table 177. Asia Oncolytic Virus Therapy Market Size Share by Countries in 2019

Table 178. China Oncolytic Virus Therapy Market Size (USD Million) and Forecast (2015-2025)

Table 179. Japan Oncolytic Virus Therapy Market Size (USD Million) and Forecast (2015-2025)

Table 180. Korea Oncolytic Virus Therapy Market Size (USD Million) and Forecast (2015-2025)

Table 181. India Oncolytic Virus Therapy Market Size (USD Million) and Forecast (2015-2025)

Table 182. Southeast Asia Oncolytic Virus Therapy Market Size (USD Million) and Forecast (2015-2025)

Table 183. South America Oncolytic Virus Therapy Market Size Share by Countries (2015-2025)

Table 184. South America Oncolytic Virus Therapy Market Size Share by Countries in 2019

Table 185. Brazil Oncolytic Virus Therapy Market Size (USD Million) and Forecast (2015-2025)

Table 186. Argentina Oncolytic Virus Therapy Market Size (USD Million) and Forecast (2015-2025)

Table 187. Middle East & Africa Oncolytic Virus Therapy Market Size Share by Countries (2015-2025)

Table 188. Middle East & Africa Oncolytic Virus Therapy Market Size Share by Countries in 2019

Table 189. Saudi Arabia Oncolytic Virus Therapy Market Size (USD Million) and Forecast (2015-2025)

Table 190. UAE Oncolytic Virus Therapy Market Size (USD Million) and Forecast (2015-2025)

Table 191. Egypt Oncolytic Virus Therapy Market Size (USD Million) and Forecast (2015-2025)

Table 192. South Africa Oncolytic Virus Therapy Market Size (USD Million) and Forecast (2015-2025)

Table 193. Global Oncolytic Virus Therapy Revenue Share by Type (2015-2020)

Table 194. Japan Oncolytic Virus Therapy Revenue Share by Type (2015-2020)

Table 195. Global Oncolytic Virus Therapy Revenue Share by Application (2015-2020)

Table 196. Japan Oncolytic Virus Therapy Revenue Share by Application (2015-2020)